On Tuesday, Zai Lab Limited ADR (NASDAQ: ZLAB) opened higher 3.02% from the last session, before settling in for the closing price of $26.18. Price fluctuations for ZLAB have ranged from $13.48 to $36.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2095.12% over the last five years. Company’s average yearly earnings per share was noted 21.57% at the time writing. With a float of $107.90 million, this company’s outstanding shares have now reached $108.14 million.
The firm has a total of 2175 workers. Let’s measure their productivity. In terms of profitability, gross margin is 63.17%, operating margin of -95.07%, and the pretax margin is -76.13%.
Zai Lab Limited ADR (ZLAB) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Zai Lab Limited ADR is 0.22%, while institutional ownership is 42.48%. The most recent insider transaction that took place on Nov 04 ’24, was worth 5,121. In this transaction Chief Financial Officer of this company sold 167 shares at a rate of $30.66, taking the stock ownership to the 15,494 shares. Before that another transaction happened on Nov 04 ’24, when Company’s Officer proposed sale 167 for $30.66, making the entire transaction worth $5,121.
Zai Lab Limited ADR (ZLAB) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 21.57% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Check out the current performance indicators for Zai Lab Limited ADR (ZLAB). In the past quarter, the stock posted a quick ratio of 2.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -1.77 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Analysing the last 5-days average volume posted by the [Zai Lab Limited ADR, ZLAB], we can find that recorded value of 0.93 million was better than the volume posted last year of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 15.54%. Additionally, its Average True Range was 1.38.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 53.23%, which indicates a significant increase from 24.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.53% in the past 14 days, which was lower than the 59.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.19, while its 200-day Moving Average is $20.90. Now, the first resistance to watch is $27.38. This is followed by the second major resistance level at $27.79. The third major resistance level sits at $28.48. If the price goes on to break the first support level at $26.28, it is likely to go to the next support level at $25.58. Now, if the price goes above the second support level, the third support stands at $25.17.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
There are currently 108,628K shares outstanding in the company with a market cap of 2.92 billion. Presently, the company’s annual sales total 266,720 K according to its annual income of -334,620 K. Last quarter, the company’s sales amounted to 102,270 K and its income totaled -41,670 K.
